People

Contract manufacturer Experic, which offers a variety of services related to dry powder inhalers, has named Sherry Ann D’Iorio as Executive Director of Business Development. D'Iorio was most recently Senior Account Director of Business Development at PPD and has previously held positions at a number of life sciences companies, including Worldwide Clinical Trials, … [Read more...] about Experic names Sherry Ann D’Iorio as Executive Director of Business Development

Texas-based Pulmotect, which is developing an inhaled immune stimulant for the treatment of respiratory diseases, has announced the appointment of Colin Broom as CEO. Broom was most recently CEO of Nabriva Therapeutics and previously served as Chief Scientific Officer at ViroPharma and in various roles at Amgen, Aventis, and GSK. Pulmotect is a spin out of … [Read more...] about Pulmotect names Colin Broom as CEO

Inhalation Sciences AB (ISAB) has announced that former ExScale Bio CEO Manoush Masarrat, who has been a member of the ISAB board of directors since January 2019, will succeed Lena Heffler as ISAB CEO. In addition to his most recent position as CEO of ExScale Bio, Masarrat has also served in sales and marketing roles at a number of companies, including Medical Vision, … [Read more...] about Inhalation Sciences names Manoush Masarrat as CEO

Milestone Pharmaceuticals has announced the appointment of former Sanofi executive Amit Hasija as Chief Financial Officer and Executive VP of Corporate Development. Milestone's etripamil, an intranasal calcium channel antagonist, is in Phase 3 development for the treatment of paroxysmal supraventricular tachycardia (PSVT). Hasija was most recently Chief Business … [Read more...] about Milestone Pharmaceuticals announces appointment of Amit Hasija as CFO and Executive VP of Corporate Development

CDMO Experic has announced the appointment of Denise Sabaday as vice president of business development. Sabaday was most recently Executive VP of Business Development and Marketing at Transformative Pharmaceutical Solutions and was previously Director of Business Development at inVentiv Health Clinical. In October 2018, Experic announced that it had hired OINDP … [Read more...] about Experic appoints Denise Sabaday as VP of Business Development

Pneuma Respiratory, which is developing a digital soft mist inhaler, has announced the appointment of Jay Morgan as Chairman of the Board. Morgan, a former Bayer and Merck executive who has been a member of the board since 2017, will replace Walt Robb as chairman. Robb will remain a member of the board. In 2018, Pneuma Respiratory announced that it had raised $8.3 … [Read more...] about Pneuma Respiratory names Jay Morgan as Chairman of the Board

Circassia Pharmaceuticals has announced the appointment of Jonathan Emms as Chief Operating Officer and as an Executive Director of the Board of Directors. Emms previously served in a number of executive roles at Pfizer, most recently as Chief Commercial Officer, Internal Medicine. The company also said that Senior VP of R&D Rod Hafner will leave the board, … [Read more...] about Circassia appoints Jonathan Emms Chief Operating Officer

AZTherapies has announced that former Dooner Laboratories and Muro Pharmaceuticals CEO George D. Behrakis has joined the company’s board of directors. Behrakis sold Dooner Laboratories, which manufactured theophylline products for asthma, to Rorer in 1977 and Muro Pharmaceuticals, which marketed a number of OINDPs for the treatment of asthma and allergies, to … [Read more...] about George D. Behrakis joins board of AZTherapies

AZTherapies, which is developing an inhaled cromolyn sodium/ibuprofen formulation, has named Jay Mohr as Chief Operating Officer, Chief Business Officer, and Head of Commercial Development. Mohr was most recently co-founder and Managing Director of Locust Walk Partners. According to his LinkedIn page, Mohr has some experience with OINDPs, beginning at … [Read more...] about AZTherapies appoints Jay Mohr as COO, Chief Business Officer, and Head of Commercial Development